LEVOTHYROX Side Effects

5825163-2 | Dehydration, Gastroenteritis, Renal Failure Acute
on Jul 17, 2008 Male patient from FRANCE , 61 years of age, was diagnosed with hypertension and was treated with Levothyrox (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, gastroenteritis (What is gastroenteritis?), renal failure acute. Levothyrox dosage: . During the same period patient was treated with PERINDOPRIL ERBUMINE (Daily Dose: 8 Milligram(s)) (View Perindopril Erbumine Review and Perindopril Erbumine Label ), MOPRAL (View Mopral Review and Mopral Label ), BURINEX (Daily Dose: 2 Milligram(s)) (View Burinex Review and Burinex Label ), IMOVANE (View Imovane Review and Imovane Label ), PRAZEPAM (View Prazepam Review and Prazepam Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ). Patient was hospitalized.

5216568-1 | Caesarean Section, Cardiac Failure, Delayed Closure Of Cranial Sutures, Dysmorphism, Echography Abnormal, Hypotonia Neonatal, Malignant Hypertension, Multiple Congenital Abnormalities
Patient was taking Levothyrox (View Usage). Patient had the following side effects: caesarean section, cardiac failure, delayed closure of cranial sutures, dysmorphism, echography abnormal, hypotonia neonatal, malignant hypertension, multiple congenital abnormalities on Jan 10, 2007 from FRANCE Additional patient health information: Male patient , weighting 7.87 lb, . Levothyrox dosage: 150 Mcg (150 Mcg,1 D). During the same period patient was treated with LODOZ (TABLET) (HYDROCHLOROTHIAZIDE, BISOPROLOL FUMARATE) (1 Dosage Forms (1 Dosage Forms,1 D)) (View Lodoz (tablet) (hydrochlorothiazide, Bisoprolol Fumarate) Review and Lodoz (tablet) (hydrochlorothiazide, Bisoprolol Fumarate) Label ), COTAREG (TABLET) (HYDROCHLOROTHIAZIDE, VALSARTAN) (1 Dosage Forms (1 Dosage Forms,1 D)) (View Cotareg (tablet) (hydrochlorothiazide, Valsartan) Review and Cotareg (tablet) (hydrochlorothiazide, Valsartan) Label ).

5038423-2 | Anaemia, Balance Disorder, Fall, Orthostatic Hypotension
Adverse event was reported on Jun 16, 2006 by a Female patient taking Levothyrox (View Usage) (Dosage: 75 Ug, Qd) was diagnosed with hypothyroidism, dysthymic disorder, essential hypertension and. Location: FRANCE , 81 years of age, weighting 172.0 lb, After Levothyrox was administered, patient had the following side effects: anaemia, balance disorder, fall (What is fall?), orthostatic hypotension. During the same period patient was treated with MOGADON (10 Mg/day) (View Mogadon Review and Mogadon Label ), LAROXYL (2 Df, Qd) (View Laroxyl Review and Laroxyl Label ), RIVOTRIL (5 Df, Qd) (View Rivotril Review and Rivotril Label ), COTAREG (1 Df, Qd) (View Cotareg Review and Cotareg Label ). Patient was hospitalized.

5029550-4 | Anaemia, Balance Disorder, Fall, Orthostatic Hypotension
on Jun 16, 2006 Female patient from FRANCE , 81 years of age, weighting 172.0 lb, was diagnosed with hypothyroidism, dysthymic disorder, essential hypertension and was treated with Levothyrox (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, balance disorder, fall (What is fall?), orthostatic hypotension. Levothyrox dosage: 75 Ug, Qd. During the same period patient was treated with MOGADON (10 Mg, Qd) (View Mogadon Review and Mogadon Label ), LAROXYL (2 Df, Qd) (View Laroxyl Review and Laroxyl Label ), RIVOTRIL (5 Df, Qd) (View Rivotril Review and Rivotril Label ), COTAREG (1 Df, Qd) (View Cotareg Review and Cotareg Label ). Patient was hospitalized.


5027535-5 | Monoparesis, Musculoskeletal Stiffness
on Jun 07, 2006 Female patient from FRANCE , 58 years of age, was diagnosed with nail tinea and was treated with Levothyrox (View Usage). Patient had the following side effects: monoparesis, musculoskeletal stiffness. Levothyrox dosage: . During the same period patient was treated with LAMISIL (1 Df, Qd) (View Lamisil Review and Lamisil Label ).

4998735-5 | Anaemia, Gastrointestinal Haemorrhage
Patient was taking Levothyrox (View Usage). After Levothyrox was administered, patient had the following side effects: anaemia, gastrointestinal haemorrhage on Mar 30, 2006 from FRANCE Additional patient health information: Female patient , 96 years of age, . Levothyrox dosage: 1.5 Dosage. During the same period patient was treated with COUMADIN (0.5 Dosage) (View Coumadin Review and Coumadin Label ), ALDACTONE (25 Mg (25 Mg, Cyclical), Oral) (View Aldactone Review and Aldactone Label ), FERROUS SULFATE TAB (1 In 1d Oral) (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), LASIX (1 D, Oral) (View Lasix Review and Lasix Label ). Patient was hospitalized.

4930396-3 | Atrial Fibrillation, Supraventricular Extrasystoles
Adverse event was reported on Feb 14, 2006 by a Female patient taking Levothyrox (View Usage) (Dosage: ) was diagnosed with hypothyroidism, depression (What is depression?), hepatitis c (What is hepatitis c?) and. Location: FRANCE , 62 years of age, Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), supraventricular extrasystoles. During the same period patient was treated with SEROPLEX FILM COATED TABLETS (View Seroplex Film-coated Tablets Review and Seroplex Film-coated Tablets Label ), SEROPLEX FILM COATED TABLETS (View Seroplex Film-coated Tablets Review and Seroplex Film-coated Tablets Label ), PEGINTERFERON ALFA 2A (View Peginterferon Alfa-2a Review and Peginterferon Alfa-2a Label ), RIBAVIRIN (View Ribavirin Review and Ribavirin Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), CLOBAZAM (View Clobazam Review and Clobazam Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ).

4883763-0 | Cardiac Failure, Cholestasis, Cytolytic Hepatitis, Fall, Ischaemic Cardiomyopathy, Pneumonia
on Dec 29, 2005 Female patient from FRANCE , 81 years of age, was diagnosed with hypothyroidism, pneumonia (What is pneumonia?), hypertensive cardiomyopathy and was treated with Levothyrox (View Usage). Patient had the following side effects: cardiac failure, cholestasis, cytolytic hepatitis, fall (What is fall?), ischaemic cardiomyopathy, pneumonia (What is pneumonia?). Levothyrox dosage: 100 Mcg (100 Mcg, 1 In 1 D), Oral/years. During the same period patient was treated with BUFLOMEDIL (TABLET) (BUFLOMEDIL) (Dosage Forms (1 Dosage Forms, 1 In 1 D), Oral/years) (View Buflomedil (tablet) (buflomedil) Review and Buflomedil (tablet) (buflomedil) Label ), AUGMENTIN (3 Gm (1 Gm, 3 In 1 D)) (View Augmentin Review and Augmentin Label ), IZILOX (TABLET) (MOXIFLOXACIN) (1 Dosage Forms (1 Dosage Forms, 1 In 1 D), Oral) (View Izilox (tablet) (moxifloxacin) Review and Izilox (tablet) (moxifloxacin) Label ), CELECTOL (200 Mg (200 Mg, 1 In 1 D), Oral/years) (View Celectol Review and Celectol Label ), AMLOR (5 MG, CAPSULE) (AMLODIPINE BESILATE) (5 Mg (5 Mg, 1 In 1 D), Oral) (View Amlor (5 Mg, Capsule) (amlodipine Besilate) Review and Amlor (5 Mg, Capsule) (amlodipine Besilate) Label ), CALCIPARINE ^SANOFI^ (SOLUTION FOR INJECTION) (HEPARIN CALCIUM) (Subcutaneous) (View Calciparine ^sanofi^ (solution For Injection) (heparin Calcium) Review and Calciparine ^sanofi^ (solution For Injection) (heparin Calcium) Label ), INSULIN (SOLUTION FOR INJECTION) (INSULIN) (Intravenous) (View Insulin (solution For Injection) (insulin) Review and Insulin (solution For Injection) (insulin) Label ). Patient was hospitalized.

4618135-7 | Autoimmune Thrombocytopenia, Condition Aggravated
on Mar 03, 2005 Female patient from , 61 years of age, was treated with Levothyrox (View Usage). After Levothyrox was administered, patient had the following side effects: autoimmune thrombocytopenia, condition aggravated. Levothyrox dosage: Oral. During the same period patient was treated with DOXYCYCLINE (Oral) (View Doxycycline Review and Doxycycline Label ), CLONIDINE (Oral) (View Clonidine Review and Clonidine Label ), ARIMIDEX (Oral) (View Arimidex Review and Arimidex Label ). Patient was hospitalized.

4560582-6 | Visual Disturbance
Patient was taking Levothyrox (View Usage). Patient experienced the following unwanted or unexpected effects: visual disturbance on Jan 17, 2005 from Additional patient health information: Female patient , 45 years of age, was diagnosed with hypothyroidism, hypercholesterolaemia and. Levothyrox dosage: . During the same period patient was treated with LESCOL (40 Mg, Qd) (View Lescol Review and Lescol Label ).